Viewing Metastatic Colorectal Cancer as a Curable Chronic Disease (Q83275968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

title

Viewing metastatic colorectal cancer as a curable chronic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

Viewing Metastatic Colorectal Cancer as a Curable Chronic Disease (English)

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

23 December 2024

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22257778

23 December 2024

1

Terence C. Chua

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22257778

23 December 2024

author name string

Winston Liauw

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

Francis Chu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

David L. Morris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22257778

23 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22257778

23 December 2024

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

February 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22257778

full work available at URL

23 December 2024

http://journals.lww.com/00000421-201202000-00014

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

American Journal of Clinical Oncology

23 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

77-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

Aetiology of adenoma--carcinoma sequence in large bowel

20 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer

23 December 2024

3

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

23 December 2024

4

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

23 December 2024

5

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

23 December 2024

6

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

23 December 2024

7

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

23 December 2024

8

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

23 December 2024

9

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

23 December 2024

10

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

23 December 2024

11

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer

23 December 2024

12

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

23 December 2024

13

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL

23 December 2024

14

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

23 December 2024

15

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

23 December 2024

16

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Recurrence and Survival Outcomes after Hepatic Resection with or without Cryotherapy for Liver Metastases from Colorectal Carcinoma

23 December 2024

17

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Actual 10-year survival after resection of colorectal liver metastases defines cure.

23 December 2024

18

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series.

23 December 2024

19

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

23 December 2024

20

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

23 December 2024

21

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

23 December 2024

22

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status

23 December 2024

23

1 reference

https://api.crossref.org/works/10.1097/COC.0B013E3181FE4444

23 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22257778 AND SRC:MED&resulttype=core&format=json

20 January 2020

1 reference